Cognyxx Pharmaceuticals
Treatment for Cardiovascular and Neurodegenerative Disorders
StartupCognyxx Pharmaceuticals is a --based startup in the Health Tech & Life Sciences sector, established in 2018. Treatment for Cardiovascular and Neurodegenerative Disorders. Cognyxx Pharmaceuticals was founded by Jacob George and Mike Fassler. The company has 1-10 employees.
The company follows a B2B business model. Product stage: R&D.
- StagePre-Funding
- ProductR&D
- ModelB2B
- Employees1-10
- HQ -
- Last RoundUndisclosed
Jacob GeorgeCo-founder
Mike FasslerCo-founder & CSO
What does Cognyxx Pharmaceuticals do?
Cognyxx Pharmaceuticals is developing a solution to empower the immune system in treatments for cardiovascular and neurodegenerative disorders.
Who founded Cognyxx Pharmaceuticals?
Cognyxx Pharmaceuticals was founded in 2018 by Jacob George (Co-founder), Mike Fassler (Co-founder & CSO).
What sector is Cognyxx Pharmaceuticals in?
Cognyxx Pharmaceuticals operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is Cognyxx Pharmaceuticals located?
Cognyxx Pharmaceuticals is based in Derech Menachem Begin 132, Tel Aviv-Yafo, Israel.